Evidence map›Paper›PMID 33117327›Full record

ArticleFrontiers in immunology2020

The Helminth Parasite

Madeleine P J White, Chris J C Johnston, John R Grainger, Joanne E Konkel, Richard A O'Connor, Stephen M Anderton, Rick M Maizels

Open access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed, 1 pooled it
2.8field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 1 synthesis or guideline pooled it, 25 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Review
  9. Parasitology · 2022
    Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Infection withPathogens (Basel, Switzerland) · 2021
    Article
  15. Review
  16. Infection and immunity · 2021
    Article
  17. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Madeleine P J WhiteWellcome Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Chris J C JohnstonClinical Surgery, Royal Infirmary of Edinburgh and University of Edinburgh, Edinburgh, United Kingdom.
John R GraingerFaculty of Biology, Medicine and Health, Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, United Kingdom.
Joanne E KonkelFaculty of Biology, Medicine and Health, Lydia Becker Institute of Immunology and Inflammation, University of Manchester, Manchester, United Kingdom.
Richard A O'ConnorMRC Centre for Inflammation Research, Centre for Multiple Sclerosis Research, Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdom.
Stephen M AndertonMRC Centre for Inflammation Research, Centre for Multiple Sclerosis Research, Centre for Immunity, Infection and Evolution, University of Edinburgh, Edinburgh, United Kingdom.
Rick M MaizelsWellcome Centre for Molecular Parasitology, Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, United Kingdom.
Centre for Immunity, Infection and Evolution · GBUniversity of Manchester · GBWellcome Centre for Molecular Parasitology · GBEdinburgh Royal Infirmary · GB

Funding

Medical Research Council MC_PC_18048Wellcome TrustWellcome Trust 104111Wellcome Trust 106122
6 · The paper itself

Abstract

Helminth parasites are effective in biasing Th2 immunity and inducing regulatory pathways that minimize excessive inflammation within their hosts, thus allowing chronic infection to occur whilst also suppressing bystander atopic or autoimmune diseases. Multiple sclerosis (MS) is a severe autoimmune disease characterized by inflammatory lesions within the central nervous system; there are very limited therapeutic options for the progressive forms of the disease and none are curative. Here, we used the experimental autoimmune encephalomyelitis (EAE) model to examine if the intestinal helminth

Indexed as

AnimalsAntigens, HelminthEncephalomyelitis, Autoimmune, ExperimentalFemaleInterleukin-4 Receptor alpha SubunitMiceMice, Inbred C57BLMice, KnockoutNematospiroides dubiusReceptors, Cell SurfaceStrongylida InfectionsTh2 CellsAntigens, HelminthIl4ra protein, mouseInterleukin-4 Receptor alpha SubunitReceptors, Cell Surfaceautoimmunitycytokineintestinal nematodemultiple sclerosis (MS)Th2 (type-2) immune responses

Identifiers

PMID33117327
PMCPMC7552805
OpenAlexW3091465156

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.